Lupin Limited (NSE:LUPIN)
India
· Delayed Price · Currency is INR 2,348.50
-19.10 (-0.81%)
Jun 25, 2026, 3:29 PM IST
Lupin Employees
Lupin had 24,006 employees as of March 31, 2025. The number of employees increased by 2,138 or 9.78% compared to the previous year.
Employees
24,006
Change (1Y)
2,138
Growth (1Y)
9.78%
Revenue / Employee
11.65M INR
Profits / Employee
2.22M INR
Market Cap
1,070.87B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Zydus Lifesciences | 27,917 |
| Mankind Pharma | 19,620 |
| Cipla | 31,369 |
| Aurobindo Pharma | 27,707 |
| Laurus Labs | 7,059 |
| Alkem Laboratories | 18,785 |
| Divi's Laboratories | 10,542 |
| Glenmark Pharmaceuticals | 15,800 |
Lupin News
- 1 day ago - Lupin Gets Tentative FDA Nod For Enzalutamide Tablets - Nasdaq
- 2 days ago - Lupin Wins FDA's Tentative Approval For Enzalutamide Tablets Across Multiple Strengths - Nasdaq
- 2 days ago - Lupin receives tentative approval from U.S. FDA for Enzalutamide tablets - Business Upturn
- 11 days ago - Lupin launches Azilsartan Medoxomil Tablets in the United States - Business Upturn
- 20 days ago - Lupin collaboraters with Spain’s ERN to launch Luforbec for Asthma and COPD treatment - Business Upturn
- 23 days ago - Lupin Wins FDA Approval For Ranluspec Biosimilar To Lucentis - Nasdaq
- 25 days ago - Lupin And Natco Receive FDA Approval For Eribulin Mesylate Injection - Nasdaq
- 25 days ago - Natco Pharma and Lupin secure U.S. FDA approval for Eribulin Mesylate Injection - Business Upturn